JCDR - Register at Journal of Clinical and Diagnostic Research
Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X
Anaesthesia Section DOI : 10.7860/JCDR/2019/42635.13384
Year : 2019 | Month : Dec | Volume : 13 | Issue : 12 Full Version Page : UC15 - UC19

The Effect of Ramelteon on Postoperative Delirium in Elderly Patients: A Randomised Double-Blind Study

Prabhat Kumar Gupta1, Reetu Verma2, Monica Kohli3, Nidhi Shukla4, Shashank Kannaujia5

1 Ex-Postgraduate Student, Department of Anaesthesiology, King George’s Medical University, Lucknow, Uttar Pradesh, India.
2 Additional Professor, Department of Anaesthesiology, King George’s Medical University, Lucknow, Uttar Pradesh, India.
3 Professor, Department of Anaesthesiology, King George’s Medical University, Lucknow, Uttar Pradesh, India.
4 Senior Resident, Department of Anaesthesiology, King George’s Medical University, Lucknow, Uttar Pradesh, India.
5 Senior Resident, Department of Anaesthesiology, King George’s Medical University, Lucknow, Uttar Pradesh, India.


NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: Reetu Verma, 538 K/781, Triveni Nagar, 2nd Sitapur Road, Lucknow, Uttar Pradesh, India.
E-mail: reetuverma1998@gmail.com
Abstract

Introduction

Delirium is known as an acute mental disturbance characterised by confused thinking and disrupted attention that is usually accompanied by disordered speech and hallucination. Delirium often is seen in patients post-surgery. Use of Melatonin pre-operatively decreases the incidence of post-operative delirium. Ramelteon is an agonist of melatonin having longer half-life than melatonin.

Aim

To evaluate the efficacy of Ramelteon for the prevention of post-operative delirium in elderly patients.

Materials and Methods

In this randomised controlled double-blind (all places) study, 50 patients with ASA I and II were selected and randomly assigned to each group. Group I received one tablet of Ramelteon (8 mg) 12 hours before surgery and 1 tablet of Ramelteon (8 mg) 1 hour before surgery and Group II received placebo one tablet 12 hours before surgery and 1 tablet 1 hour before surgery. Incidence of delirium was assessed by Confusion Assessment Method (CAM) at 1st, 2nd and 3rd day. The SPSS Version 21.0 was used for the statistical analyses and p-value <0.05 was considered as significant. The Chi-square test was used to compare the categorical variables between the groups. Unpaired t-test was used to compare the continuous variables between the groups.

Results

Only two patients developed delirium in Ramelteon group, one patient at Day 2 and one patient at Day 3; but in control group, six patients develop delirium, three patients at day two and three patients at Day 3. The incidence of delirium in Ramelteon group was lower in comparison with placebo group but it was not statistically significant.

Conclusion

Thus, it was observed that Ramelteon administration in pre-operative period decreases (non-significantly) the incidence of post-operative delirium with higher sedation scores. So Ramelteon can be recommended in the patients having high risk of developing post-operative delirium.

Keywords

Introduction

Delirium, which is an acute condition with fluctuating course, is characterised by disturbances in attention combined with either a change in level of consciousness or disorganised thinking. The aetiology of delirium is multi-factorial and it may be surgery, admission to intensive care unit, primary neurological disorder, psychoactive drug, etc., [1,2]. Post-operative delirium is common in elderly age group and incidence of post-operative delirium ranges from 10% to 61% in elderly age group [3]. The recognition and treatment of post-operative delirium are important because it leads to increased duration of hospital stay and mortality [4].

Melatonin (N-acetal-5-methoxy-traptamine) is a hormone formed from Tryptophan, secreted by pineal gland and it plays an important role in the regulation of sleep wake sleep cycle [5]. A strong correlation has been seen between post-operative delirium and changes in melatonin secretion [6]. Synthetic melatonin supplements when used as premedication found to improve post-operative cognitive profile [7].

Ramelteon, a melatonin agonist was approved by US Food and drug administration for treatment of insomnia and has been suggested for prevention of delirium [8]. Ramelteon is a tricyclic synthetic analog of melatonin with chemical name (S)-N-[2-(1,6,7,8-tetrahydro-2H-indeno{5,4-b}furan-8-71) ethyl] propionamide [9,10]. Ramelteon has more affinity for melatonin receptor MT1 and MT2 compared with melatonin [11,12]. The reason for this is the unique molecular structure of Ramelteon i.e., a propionyl group instead of acetyl group, two hydrocarbon atoms in a furan ring instead of a methoxy group and its lack of nitrogen in 5-atom ring, causing more tissue distribution than melatonin. The effectiveness of Ramelteon has attributed to its higher penetration and half-life of 1-2 hours in comparison to melatonin whose half-life is approximately 30 minutes [13]. Also, one of the Ramelteon’s metabolites MTII have functional half-life of 5 hours thus making Ramelteon superior to melatonin [8]. Consequently, Ramelteon also desensitises MT1 and MT2 receptors more than melatonin itself [14].

To the best of authors’ knowledge, very few studies have been done to assess the role of Ramelteon in prevention of post-operative delirium in elderly patient [15,16]. So this study was done to evaluate the role of Ramelteon in prevention of post-operative delirium in elderly patient.

The primary objective of this study was to compare incidence of post-operative delirium in elderly patients using the CAM between Ramelteon and control group. The secondary objective was to compare the intraoperative haemodynamics, Ramsay Sedation Score (RSS), post-operative Ramsay sedation Score and any complications between ramethe twolteon and control group.

Materials and Methods

This randomised double-blind study was carried out at the Department of Anaesthesiology, King George Medical University, Lucknow, Uttar Pradesh. After approval by the Institutional Ethics Committee (89th ECM II B Thesis/P14), patients age more than 65 years, admitted to Gandhi Memorial and Associate Hospitals, King George’s Medical University, Lucknow, undergoing surgery at various surgical departments were recruited for this study.

Patients belonging to the American society of Anesthesiologists (ASA) physical status Grade 1 and 2 and planned for surgery requiring neuraxial anaesthesia for duration longer than one hour were included. Patients with history of dementia, severe infections, intracranial bleed, having any acute cardiac event and taking any psychiatric medications were excluded from the study. Hundred patients were randomly distributed in two groups with each group containing 50. It was calculated to be 50 in each group on the basis of sensitive and specification of CAM [17] using the formula:

where Sn=0.8 sensitive; Sp=0.959 specificity CAM; d=2, effect for multiple assessment parameters; Type I error α=5%; Type II error β=20% for 80% power of study.

Randomisation was done according to a computer-generated list. Group I (Ramelteon group): Received oral ramelteon; one tablet of ramelteon (8 mg) 12 hours before surgery and 1 tablet of ramelteon (8 mg) 1 hour before surgery.

Group II (Control group): Received placebo tablets; one tablet 12 hours before surgery and 1 tablet 1 hour before surgery [Table/Fig-1].

CONSORT Flow Diagram.

After obtaining written informed consent from patients, the complete medical history, physical examination and mini-mental examination were done for all patients [Table/Fig-2]. Study drug was given in a sealed envelope to all patients by the anaesthetist who was not involved in the observation of the patients and asked to take 1st dose 12 hours before surgery and 2nd dose 1 hour before surgery. It was a double-blind study as observer was not involved in giving the study drug to patients and patients were also not aware which study drug was given to them. No sedative drug was given to the patient preoperatively. After arrival in an operation theatre, standard monitors were attached which include pulse oximeter (SpO2), ECG, non-invasive blood pressure monitoring. All these parameters were recorded and monitoring continued throughout intraoperatively. On arrival in operation theatre, patients Ramsay sedation score was noted and thereafter every hour till completion of surgery. All patients were given combined spinal and epidural anaesthesia. On the 1st day of surgery, epidural infusion was used for post-operative analgesia. On 2nd day and 3rd day, Inj. Paracetamol 1 gm IV 6 hourly was used for post-operative analgesia.

Mini-mental state examination (MMSE).

Instructions: Ask the questions in the order listed. Score one point for each correct response within each question or activity.
Maximum scorePatient’s scoreQuestions
5“What is the year? Season? Date? Day of the week? Month?”
5Where are we now: State? Country? Town/city? Hospital? Floor?”
3The examiner names three unrelated objects clearly and slowly, then asks the patient to name all three of them. The patient’s response is used for scoring. The examiner repeats them until patient learns all of them, if possible. Number of trials: ___________
5“I would like you to count backward from 100 by sevens.” (93, 86, 79, 72, 65, …) Stop after five answers. Alternative: “Spell WORLD backwards.” (D-L-R-O-W)
3“Earlier I told you the names of three things. Can you tell me what those were?”
2Show the patient two simple objects, such as a wristwatch and a pencil, and ask the patient to name them.
1“Repeat the phrase: ‘No ifs, ands, or buts.’”
3Take the paper in your right hand, fold it in half, and put it on the floor.” (The examiner gives the patient a piece of blank paper.)
1“Please read this and do what it says.” (Written instruction is “Close your eyes.”)
1“Make up and write a sentence about anything.” (This sentence must contain a noun and a verb.)
1“Please copy this picture.” (The examiner gives the patient a blank piece of paper and asks him/her to draw the symbol below. All 10 angles must be present and two must intersect.)
30Total
Interpretation of the MMSE
MethodScoreInterpretation
Single cut-off<24Abnormal
Range<21Increased odds of dementia
>25Decreased odds of dementia
Education21Abnormal for 8th grade education
<23Abnormal for high school education
<24Abnormal for college education
Severity24-30No cognitive impairment
18-23Mild cognitive impairment
0-17Severe cognitive impairment

Delirium was assessed by CAM on 1st, 2nd and 3rd day [Table/Fig-3]. Intraoperative Ramsay sedation score [Table/Fig-4] was observed. Intraoperative haemodynamic (BP, Heart Rate, SpO2) were recorded at baseline to 30 minutes at every 5 minutes and subsequently every 15 minutes. Post-operative Ramsay sedation score was observed immediately after surgery, after 6 and 24 hours.

Confusion Assessment Method (CAM).

The diagnosis of delirium by CAM requires the presence of both features A and B
A. Acute onset and fluctuating courseIs there evidence of an acute change in mental status from patient baseline? Does the abnormal behavior:

come and go?

fluctuate during the day?

increase/decrease in severity?

B. InattentionDoes the patient:

have difficulty focusing attention?

become easily distracted?

have difficulty keeping track of what is said?

And the presence of either feature C or D
C. Disorganised thinkingIs the patient’s thinking

Disorganised

Incoherent

For example does the patient have rambling speech/irrelevant conversation?

unpredictable switching of subjects?

unclear or illogical flow of ideas?

D. Altered level of consciousnessOverall, what is the patient’s level of consciousness:

alert (normal)

vigilant (hyper-alert)

lethargic (drowsy but easily roused)

stuporous (difficult to rouse)

comatose (unrousable)


Ramsay sedation scale.

Ramsay 1Anxious, agitated, restless
Ramsay 2Cooperative, oriented, tranquil
Ramsay 3Responsive to commands only If asleep
Ramsay 4Brisk response to light glabellar tap or loud auditory stimulus
Ramsay 5Sluggish response to light glabellar tap or loud auditory stimulus
Ramsay 6No response to light glabellar tap or loud auditory stimulus

Statistical Analysis

All the data for continuous variables (age, disease duration, HR, MAP, SpO2 and MMSE) are shown as the mean±standard deviation and the categorical variable (gender) is shown as a percentage. The total scores on the MMSE were calculated as the sum of single items. The Chi-square test was used to compare the categorical variables between the groups. Unpaired t-test was used to compare the continuous variables between the groups. The SPSS Version 21.0 statistical Analysis Software was used for the statistical analyses. p<0.05 was considered to indicate a statistically significant difference.

Results

The demographic variables such as age, gender, ASA grade and baseline hemodynamic parameters were comparable between Group l and Group ll as shown in [Table/Fig-5]. This study included patients of age between 65-82 years. Mean age of patients was comparable in between group I (69.30±4.05 years) and Group II (70.64±3.76 years) and male preponderance was observed. Pre-operative heart rate, systolic BP and diastolic BP of patients were found to be comparable in both groups (p>0.05).

Between group comparison of demographic variables.

Group I (n=50)Group II (n=50)p-value
Age (years) Mean±SD69.30±4.0570.64±3.760.090#
Gender
Female15 (30.0%)17 (34.0%)0.668#
Male35 (70.0%)33 (66.0%)
ASA grade
Grade I31 (62.0%)31 (62.0%)
Grade II19 (38.0%)19 (38.0%)1.00#
Hemodynamic variables
Heart rate86.98±12.7683.32±9.000.101#
Systolic BP132.38±11.90131.78±7.380.763#
Diastolic BP77.54±9.1779.30±6.360.267#

Data are represented as mean±SD, n (%) and ratio. SD=Standard deviation

#p-value not significant; *p-value significant


At the time of enrolment none of the patients in the study was found to be suffering from dementia, severe infection, intracranial events, MI, CHF, arrhythmias, COPD or Pulmonary embolism. Associated illness in the population was higher in Group II as compared to group I for prevalence of hypertension (22.0% vs. 20.0%) and diabetes (18.0% vs. 16.0%) but these differences were not found to be statistically significant. Whereas prevalence of Asthma was higher in group I as compared to Group II (6.0% vs. 4.0%) but this difference was also not found to be statistically significant.

Mental status of the patients was assessed using Mini-Mental Status examination. MMSE score was found to be higher in group I (27.22±1.33) as compared to that of Group II (27.19±1.82) but this difference was not statistically significant.

Patients were admitted for surgical intervention of different ailments and were admitted in the respective speciality wards. Among patients of Group I admissions to Urology wards were most common followed by Orthopedics while among patients of Group II admissions to Urology and Orthopedics wards were most common. Proportional difference in patients of above two groups admitted to different speciality wards was not found to be statistically significant (p=0.474).

Mean Heart rate of patients of Group I was found to be higher as compared to that of Group II except at 25 minutes and 150 minutes. Difference in mean heart rate of patients of above two groups was not found to be statistically significant at any of the periods of observation [Table/Fig-6].

Comparison of heart rate (Beats/minute).

Systolic BP of patients of group I was found to be higher as compared to that of Group II at baseline, 5 minutes, 20 minutes, 25 minutes, 30 minutes while at rest of the periods of observation, SBP of Group II was higher as compared to that of group I, but difference in mean systolic BP of patients of two groups was found to be statistically significant only at 25 minutes (119.46±11.68 vs. 111.92±5.15 mmHg) [Table/Fig-7].

Comparison of Systolic Blood Pressure (mm of Hg).

Mean Diastolic BP of patients of Group II was found to be higher as compared to that of Group I at all the periods of observation except at 25 minutes, and differences in mean diastolic BP of patients of above two groups was found to be statistically significant at all the periods of observation except at baseline, 5 minutes, 20 minutes and 30 minutes [Table/Fig-8].

Comparison of Diastolic Blood Pressure (mm of Hg).

Oxygen saturation level of all the patients during the period of observation was maintained above 95% hence this difference has no clinical relevance.

Sedation score of all the patients just before surgery was 2.00. Mean sedation score of patients of group I (2.32±0.62) was found to be higher as compared to that Group II (2.08±0.63). Difference in Ramsay sedation score of patients of above two groups was not found to be statistically significant at any of the period of observation [Table/Fig-9].

Ramsay Sedation Score at different time intervals.

Time intervalGroup I (Mean±SD)Group II (Mean±SD)Mann Whitney U test
‘Z’‘p’
0 h2.00±0.002.00±0.000.0001.000#
1 h2.32±0.622.08±0.631.8930.058#
2 h2.32±0.622.08±0.631.8930.058#
3 h2.09±0.54---
Immediate post-surgery2.32±0.622.08±0.631.8930.058#
6 h post-operative2.32±0.622.08±0.631.8930.058#
24 h post-operative2.32±0.622.08±0.631.8930.058#

#p-value not significant; *p-value significant


Confusion assessment method was used to assess the post-operative delirium on follow-up at Day 1, Day 2 and Day 3. Total incidence of delirium was 8%; lower in group I as compared to Group II (4% vs 12%). On day 2, one patient developed delirium in group I while 3 patients developed delirium in Group II but difference was not found to be statistically significant. On day 3, one patient developed delirium in group I and 3 patients in Group II but difference was not statically significant. None of the patients, irrespective of any of the groups was positive for CAM on follow-up at Day 1 [Table/Fig-10].

Comparison of positive CAM on follow-up.

Day of follow-upGroup I (n=50)Group II (n=50)p-value
Day 10 (0.0%)0 (0.0%)-
Day 21 (2.0%)3 (6.0%)0.307#
Day 31 (2.0%)3 (6.0%)0.307#

#p-value not significant; *p-value significant


Discussion

Post-operative delirium is one of post-operative neurological complication, which is seen, in elderly patients who are of age more than 65 years. This leads to prolonged hospital stay and an increasing need for rehabilitation and home care. So, this study was conducted to evaluate the effect of Ramelteon on post-operative delirium as primary objective and its effect on haemodynamic responses and sedation scores in elderly patients as secondary objectives.

Demographic variables were compared between two groups. The aetiology of post-operative is multifactorial and some of the predisposing factors are like pulmonary disease, pre-operative cognitive dysfunction, patient on antiarrhythmic and use of opioids [18,19]. These factors were comparable between two groups in this study. Post-operative delirium was determined using CAM on day 1,2,3. CAM has more than 90% sensitivity and specificity in elderly patients [20,21]. Wei LA et al., found CAM scale to be a reliable tool to evaluate post-operative delirium if used by trained personnel [22].

In this study, it was observed that the incidence of delirium in Ramelteon group was lower in comparison with placebo group but it was not statistically significant; similar to other studies that reported that Ramelteon prolongs the time to development of delirium and decreases the frequency of delirium [12,16]. Hatta K et al., did a multicenter randomised placebo-control trial in ICU and observed that there was decrease in delirium after Ramelteon administration (3% vs 32%, p=0.003) [12]. Miyata R et al., did a retrospective analysis of patients of age 70 years or more undergoing anatomical pulmonary resection for lung cancer and observed that incidence of delirium was lower in the Ramelteon group in comparison to control group (p=0.061) [15]. Similarly, Booka E et al., studied 65 patients who underwent pharyngo-larygectomy with oesophagectomy and observed that Ramelteon was associated with significantly decreased incidence of delirium in post-operative period [16].

In this study, post-operative delirium developed on day second and day third. Whitlock EL et al., also observed that post-operative delirium usually peaks between first and third day [19]. The total incidence of delirium in this study was 8% which is lesser than previously reported studies [15,16]. The difference may be due to inclusion of patients undergoing surgery only under regional anaesthesia. Although perioperative anaesthesia can affect the development of post-operative delirium, all patients in this study received similar perioperative anaesthesia technique and analgesic administration under the same perioperative anaesthetic policy.

Intra-operatively, the haemodynamic variable such as heart rate was comparable in both Ramelteon and placebo groups but there were more changes in placebo group. These findings are supported by other studies, that reported that from the baseline values, the change in heart rate between the study groups were found to be non-significant at any given time interval [23,24]. Although no significant decrease in MAP was noted in the Ramelteon group but melatonin was found to have a mild hypotensive effect due to the direct action on vascular melatonin receptors and the reduction of the adrenergic outflow and catecholamine levels [25]. This property of melatonin was utilised in eye surgeries where 10 mg melatonin given orally 90 minutes before the operation in cataract surgery patients provided significant sedation and lowering of intraocular pressure [26]. In the present study, the overall mean arterial pressures were found to be on higher side in Ramelteon as compared to placebo groups although it was not statistically significant. The difference in SpO2 was not found to be statistically significant among different study groups at any given time intervals. Throughout the intraoperative period, the SpO2 was maintained at 96-100% with no episode of fall in saturation at any point of time.

The difference in Ramsay sedation score of patients of the two groups was not statistically significant at any of the period of observation. Patients in the Ramelteon group had higher sedation scores as compared to placebo group but none had respiratory depression. Mallick S et al., compared the effect of Ramelteon and placebo on perioperative sedation in cases of laparoscopic cholecystectomies and they also reported that the sedation score was significantly higher in Ramelteon groups compared to the placebo group after 30 minutes and 60 minutes of administration of drug [27]. Borazan H et al., and Naguib M et al., also reported that the sedation score was markedly higher in the melatonin group than in control group [28,29]. Various studies suggested that the Ramelteon increased sedation effects in a dose-independent manner [30-32].

Limitation

The main limitation of this study is that it is a single-centre study. Also, all surgical specialties were included, which could have effected the total incidence of delirium so studies focusing on single speciality patients are required.

Conclusion

Ramelteon decreases the incidence of post-operative delirium with higher sedation scores. So Ramelteon can be recommended in patients having high risk of developing post-operative delirium. The scope of further research on Ramelteon includes the use of Ramelteon in higher doses and post-operative continuation of Ramelteon, and its effects on the delirium, sedative effects and hemodynamic variables can be studied.

Data are represented as mean±SD, n (%) and ratio. SD=Standard deviation#p-value not significant; *p-value significant#p-value not significant; *p-value significant#p-value not significant; *p-value significant

References

[1]Siddiqi N, House AO, Holmes JD, Occurrence and outcome of delirium in medical in-patients: a systematic literature review Age Ageing 2006 35(4):350-64.10.1093/ageing/afl00516648149  [Google Scholar]  [CrossRef]  [PubMed]

[2]Inouye SK, Charpentier PA, Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability JAMA 1996 275(11):852-57.10.1001/jama.1996.035303500340318596223  [Google Scholar]  [CrossRef]  [PubMed]

[3]Young J, Inouye SK, Delirium in older people BMJ 2007 334(7598):842-46.10.1136/bmj.39169.706574.AD17446616  [Google Scholar]  [CrossRef]  [PubMed]

[4]Abelha FJ, Luís C, Veiga D, Parente D, Fernandes V, Santos P, Outcome and quality of life in patients with postoperative delirium during an ICU stay following major surgery Crit Care 2013 Oct 29 17(5):R25710.1186/cc1308424168808  [Google Scholar]  [CrossRef]  [PubMed]

[5]Brzezinski A, Melatonin in humans N Engl J Med 1997 336(3):186-95.10.1056/NEJM1997011633603068988899  [Google Scholar]  [CrossRef]  [PubMed]

[6]Shigeta H, Yasui A, Nimura Y, Machida N, Kageyama M, Miura M, Postoperative delirium and melatonin levels in elderly patients Am J Surg 2001 182(5):449-54.10.1016/S0002-9610(01)00761-9  [Google Scholar]  [CrossRef]

[7]Sultan SS, Assessment of role of perioperative melatonin in prevention and treatment of postoperative delirium after hip arthroplasty under spinal anesthesia in the elderly Saudi J Anaesth 2010 4(3):169-73.10.4103/1658-354X.7113221189854  [Google Scholar]  [CrossRef]  [PubMed]

[8]Pandi-Perumal SR, Spence DW, Verster JC, Srinivasan V, Brown GM, Cardinali DP, Pharmacotherapy of insomnia with ramelteon: safety, efficacy and clinical applications J Cent Nerv Syst Dis 2011 3:51-65.10.4137/JCNSD.S161123861638  [Google Scholar]  [CrossRef]  [PubMed]

[9]Kato K, Hirai K, Nishiyama K, Uchikawa O, Fukatsu K, Ohkawa S, Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist Neuropharmacology 2005 48(2):301-10.10.1016/j.neuropharm.2004.09.00715695169  [Google Scholar]  [CrossRef]  [PubMed]

[10]Miyamoto M, Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders CNS Neurosci Ther 2009 15(1):32-51.10.1111/j.1755-5949.2008.00066.x19228178  [Google Scholar]  [CrossRef]  [PubMed]

[11]Uchikawa O, Fukatsu K, Tokunoh R, Kawada M, Matsumoto K, Imai Y, Synthesis of a novel series of tricyclic indan derivatives as melatonin receptor agonists J Med Chem 2002 45(19):4222-39.10.1021/jm020115912213063  [Google Scholar]  [CrossRef]  [PubMed]

[12]Hatta K, Kishi Y, Wada K, Takeuchi T, Odawara T, Usui C, Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial JAMA Psychiatry 2014 71:397-403.10.1001/jamapsychiatry.2013.332024554232  [Google Scholar]  [CrossRef]  [PubMed]

[13]Karim A, Tolbert D, Cao C, Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT1 and MT2 melatonin receptor agonist indicated for treatment of insomnia J Clin Pharmacol 2006 46(2):140-48.10.1177/009127000528346116432265  [Google Scholar]  [CrossRef]  [PubMed]

[14]Williams WP, McLin DE, Dressman MA, Neubauer DN, Comparative review of approved melatonin agonists for the treatment of circadian rhythm sleep wake disorders Pharmacotherapy 2016 36(9):1028-41.10.1002/phar.182227500861  [Google Scholar]  [CrossRef]  [PubMed]

[15]Miyata R, Omasa M, Fujimoto R, Ishikawa H, Aoki M, Efficacy of Ramelteon for delirium after lung cancer surgery Interact Cardiovasc Thorac Surg 2017 24:08-12.10.1093/icvts/ivw29727624354  [Google Scholar]  [CrossRef]  [PubMed]

[16]Booka E, Tsubosa Y, Matsumoto T, Takeuchi M, Kitani T, Nagaoka M, Postoperative delirium after pharyngolaryngectomy with esophagectomy: A role for ramelteon and suvorexant Esophagus 2017 14(3):229-34.10.1007/s10388-017-0570-z28725169  [Google Scholar]  [CrossRef]  [PubMed]

[17]Gusmao-Flores D, Salluh JI, Chalhub , Quarantini LC, The confusion assessment method for the intensive care unit (CAM-ICU) and intensive care delirium screening checklist (ICDSC) for the diagnosis of delirium: a systematic review and meta-analysis of clinical studies Crit Care 2012 16:R11510.1186/cc1140722759376  [Google Scholar]  [CrossRef]  [PubMed]

[18]Sprung J, Roberts RO, Weingarten TN, Nunes Cavalcante A, Knopman DS, Petersen RC, Postoperative delirium in elderly patients is associated with subsequent cognitive impairment Br J Anaesth 2017 119:316-23.10.1093/bja/aex13028854531  [Google Scholar]  [CrossRef]  [PubMed]

[19]Whitlock EL, Vannucci A, Avidan MS, Postoperative delirium Minerva Anestesiol 2011 77:448-56.  [Google Scholar]

[20]Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI, Clarifying confusion: the confusion assessment method: a new method for detection of delirium Ann Intern Med 1990 113(12):941-48.10.7326/0003-4819-113-12-9412240918  [Google Scholar]  [CrossRef]  [PubMed]

[21]Voyer P, Richard S, Doucet L, Carmichael PH, Detecting delirium and subsyndromal delirium using different diagnostic criteria among demented long-term care residents J Am Med Dir Assoc 2009 10(3):181-88.10.1016/j.jamda.2008.09.00619233058  [Google Scholar]  [CrossRef]  [PubMed]

[22]Wei LA, Fearing MA, Sternberg EJ, Inouye SK, The Confusion Assessment Method: A systematic review of current usage J Am Geriatr Soc 2008 56(5):823-30.10.1111/j.1532-5415.2008.01674.x18384586  [Google Scholar]  [CrossRef]  [PubMed]

[23]Aggarwal M, Gupta P, Jethava D, Jethava DD, Efficacy of Melatonin as an adjuvant in lower limb surgeries performed under spinal anaesthesia and its role in preventing post-operative delirium IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) 2018 17:10-19.  [Google Scholar]

[24]Yildiz M, Sahin B, Sahin A, Acute effects of oral melatonin administration on arterial distensibility, as determined by carotidfemoral pulse wave velocity, in healthy young men ExpClinCardiol 2006 11(4):311-13.  [Google Scholar]

[25]Kurdi MS, Patel T, The role of melatonin in anaesthesia and critical care Indian J Anaesth 2013 57:137-44.10.4103/0019-5049.11183723825812  [Google Scholar]  [CrossRef]  [PubMed]

[26]Ismail SA, Mowafi HA, Melatonin provides anxiolysis, enhances analgesia, decreases intraocular pressure and promotes better operating conditions during cataract surgery under topical anaesthesia Anesth Analg 2009 108:1146-51.10.1213/ane.0b013e3181907ebe19299777  [Google Scholar]  [CrossRef]  [PubMed]

[27]Mallick S, Mandal US, Halder A, Moulik SG, Hazra SK, Biswas A, Comparison of ramelteon with clonidine as an adjuvant to anesthesia: A placebo-controlled, randomized, double-blinded trial Karnataka Anaesth J 2015 1:37-41.10.4103/2394-6954.163068  [Google Scholar]  [CrossRef]

[28]Borazan H, Tuncer S, Yalcin N, Erol A, Otelcioglu S, Effects of preoperative oral melatonin medication on postoperative analgesia, sleep quality, and sedation in patients undergoing elective prostatectomy: a randomized clinical trial J Anesth 2010 24(2):155-60.10.1007/s00540-010-0891-820186437  [Google Scholar]  [CrossRef]  [PubMed]

[29]Naguib M, Samarkandi AH, Moniem MA, Mansour Eel-D, Alshaer AA, AlAyyaf HA, The effects of melatonin premedication on propofol and thiopental induction dose-response curves: a prospective, randomized, double-blind study AnesthAnalg 2006 103(6):1448-52.10.1213/01.ane.0000244534.24216.3a17122221  [Google Scholar]  [CrossRef]  [PubMed]

[30]Roth T, Seiden D, Sainati S, Wang-Weigand S, Zhang J, Zee P, Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia Sleep Med 2006 7:312-18.10.1016/j.sleep.2006.01.00316709464  [Google Scholar]  [CrossRef]  [PubMed]

[31]Roth T, Stubbs C, Walsh J, Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment Sleep 2005 28:303-07.  [Google Scholar]

[32]Erman M, Seiden D, Zammit G, Sainati S, Zhang J, An efficacy, safety, and dose-response study of ramelteon in patients with chronic primary insomnia Sleep Med 2006 7:17-24.10.1016/j.sleep.2005.09.00416309958  [Google Scholar]  [CrossRef]  [PubMed]